Earnings

The company reported earnings of $222.2 million, or $1.10 per share, up from $211 million, or $1.07 per share, a year ago. Excluding special items, earnings were $248 million, or $1.23 per share. On average, analysts expected to see adjusted EPS of $1.14.

Revenue
Sales rose 7% to $1.54 billion from $1.44 billion a year ago. Analysts expected to see revenue of $1.52 billion.

Outlook
Looking forward to FY2015, the company expects to see earnings between $3.90 and $4.00 per share and comparable earnings between $4.25 and $4.35 per share. Analysts expect to see $4.24 per share in earnings.

The company had a great year in 2014, as its shares rose 40%. We view this stock as expensive as it is currently trading at 25x 2015 earnings estimates. Although the company benefits from low competition, investors and fund managers would be paying a premium for the stock at current levels. While there is still momentum potential, shares of STZ are still pricey.

For investors seeking exposure to STZ, the mutual funds below may be good alternatives to investing directly in the stock. These funds currently hold the largest stakes in the company.

The funds above could be good options for investors seeking exposure to STZ, but would prefer not to purchase the stock. Investors interested in STZ may also be interested in Brown-Forman (BF-B) and Molson Coors (TAP).